NCT07320586
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
- Locations
-
- Shandong First Medical University Affiliated Cancer Hospital Jinan, Shandong, China
Clinical trial condition
Second-line Therapy
Explore clinical trials studying Second-line Therapy. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Second-line Therapy trial results
Not Yet Recruiting
A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors
NCT07343453
- Conditions
- Advanced Stage, Second-line Therapy, Thymic Epithelial Tumors
- Locations
-
Not specified
Active, Not Recruiting
Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC
NCT07703228
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China